RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Beyond Statins in Treatment of Dyslipidemia
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28 suppl 1
SP 15
OP 16
DO 10.1177/1559897715613086
UL http://mdc.sagepub.com/content/15/28_suppl_1/15.abstract
AB A reservoir of risk in the treatment of dyslipidemia calls for optimization of statin treatment, which involves monitoring of response and compliance and adjustment of dose as needed. Also, other therapeutic approaches are needed. Niacin and fibrates are questionable options. Ezetimibe, PCSK9 inhibitors, mipomersen, and lomitapide have potential merit.